Klivira
Request demo

Optimizing Allergy & Immunology Availity Integration for Efficient Prior Authorizations

Klivira streamlines **allergy & immunology Availity integration**, automating prior authorizations for high-cost biologics and critical therapies, ensuring faster patient access to essential care.

Revenue cycle leaders and prior authorization coordinators in allergy & immunology practices face significant administrative burdens managing complex PAs for specialized treatments. Manual navigation of multi-payer portals like Availity consumes valuable staff time and delays patient care. Klivira provides a robust solution to automate these workflows, enhancing efficiency and reducing operational costs.

The Landscape of Prior Authorization in Allergy & Immunology

Allergy & Immunology prior authorizations frequently involve high-cost, specialty medications and complex therapies. Treatments such as biologics (e.g., Xolair, Dupixent, Nucala), IVIG/SCIG, and allergen immunotherapy often require extensive documentation and specific payer approvals. These PAs are critical for patient access but can significantly impact clinic efficiency and patient care timelines.

Availity Integration: A Central Hub for Allergy & Immunology PAs

Availity serves as a critical multi-payer clearinghouse, facilitating prior authorization submissions for a vast network of commercial payers. For allergy & immunology practices, leveraging Availity integration effectively means consolidating numerous payer-specific workflows into a more manageable interface, though manual portal interactions still present a significant challenge.

Common Prior Authorization Triggers for Allergy & Immunology via Availity

  • Specialty Biologics: Xolair (omalizumab), Dupixent (dupilumab), Nucala (mepolizumab), Fasenra (benralizumab) for severe asthma and other allergic conditions.
  • Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) for primary immunodeficiencies.
  • Allergen Immunotherapy (AIT) beyond initial evaluation, especially for complex protocols.
  • Advanced Diagnostic Imaging: CT scans or specific pulmonary function tests (PFTs) when deemed medically necessary by payer policies.
  • Specific Allergy Testing Panels: Beyond routine skin prick tests, depending on payer coverage criteria.

EMR and Payer Workflow Touchpoints

Prior authorization workflows in allergy & immunology typically initiate from EMR order entry for biologics or IVIG. Klivira integrates directly with leading EMR systems via SMART on FHIR, capturing necessary clinical data. This data is then translated into standardized formats like X12 278 or ePA (NCPDP SCRIPT) for submission through channels like Availity, minimizing manual data entry and ensuring compliance with payer-specific documentation requirements.

Clinical Guidelines Informing Allergy & Immunology Prior Authorizations

  • American Academy of Allergy, Asthma & Immunology (AAAAI) practice parameters.
  • American College of Allergy, Asthma & Immunology (ACAAI) guidelines.
  • National Heart, Lung, and Blood Institute (NHLBI) guidelines for asthma management.
  • Specific drug prescribing information and FDA-approved indications.
  • Da Vinci PAS implementation guides for standardized data exchange.

Automating Availity Submissions for Allergy & Immunology Workflows

Klivira's platform automates the entire prior authorization lifecycle, from initial submission to status checks and appeals, specifically for allergy & immunology cases routed through Availity. By digitally extracting clinical documentation from the EMR and intelligently populating payer portals, Klivira reduces the need for manual Availity portal navigation, accelerating approval times and improving staff productivity.

Frequently asked questions

How does Klivira integrate with Availity for allergy & immunology prior authorizations?

Klivira integrates with Availity through secure, API-driven connections, enabling automated submission of prior authorization requests. Our platform extracts relevant clinical data from your EMR, formats it according to payer requirements, and submits it via Availity's clearinghouse, eliminating manual portal entry for allergy & immunology cases.

What specific prior authorization types for allergy & immunology are supported via Availity integration?

Klivira supports a wide range of allergy & immunology prior authorization types, including those for high-cost biologics (e.g., Xolair, Dupixent), IVIG/SCIG therapies, and complex allergen immunotherapy. Our system is configured to handle the specific documentation required for these specialty treatments through Availity.

Can Klivira assist with required clinical documentation for biologics PA submitted through Availity?

Yes, Klivira's intelligent automation identifies and extracts necessary clinical documentation from your EMR, such as diagnosis codes, lab results, and treatment history, which are critical for biologics prior authorizations. This data is then automatically attached or transmitted with the Availity submission, ensuring comprehensive requests.

How does Klivira ensure PHI security during Availity prior authorization submissions?

Klivira adheres to stringent HIPAA compliance standards, employing robust encryption, access controls, and audit trails to protect PHI throughout the prior authorization process. All data exchanges with EMRs and multi-payer platforms like Availity are conducted via secure, compliant channels, ensuring the integrity and confidentiality of patient information.

Which EMR systems are compatible with Klivira's allergy & immunology Availity integration?

Klivira offers deep integration capabilities with major EMR systems commonly used in allergy & immunology practices, including Epic, Cerner, Athenahealth, and others. Our platform leverages industry standards like SMART on FHIR to ensure seamless data flow and workflow automation for prior authorizations.

Related coverage

Other allergy-immunology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo